Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Zalaudek, I; Corneli, P; Vernoni, S; Fedele, D; Papa, G; Conforti, C; Retrosi, C; Vezzoni, R; Fagotti, S; Longone, M; Farinazzo, E; di, Meo, N; Pizzichetta, MA.
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.
Dermatol Ther. 2019; 32(6): e13107
Doi: 10.1111/dth.13107
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Zalaudek Iris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Aged - administration & dosage
- Antibodies, Monoclonal, Humanized - therapeutic use
- Carcinoma, Squamous Cell - drug therapy, pathology
- Drug Resistance, Neoplasm - administration & dosage
- Humans - administration & dosage
- Male - administration & dosage
- Neoplasm Staging - administration & dosage
- Programmed Cell Death 1 Receptor - antagonists & inhibitors
- Skin Neoplasms - drug therapy, pathology